Infleqtion (NYSE:INFQ – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten analysts that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation, six have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $19.57.
INFQ has been the subject of a number of research analyst reports. Wedbush began coverage on Infleqtion in a research report on Monday, August 3rd. They set an “outperform” rating and a $20.00 price target for the company. BTIG Research reissued a “buy” rating and issued a $25.00 price objective on shares of Infleqtion in a research report on Friday, September 25th. Wall Street Zen upgraded Infleqtion from a “strong sell” rating to a “sell” rating in a research note on Sunday. Morgan Stanley began coverage on Infleqtion in a research report on Thursday, October 15th. They set an “equal weight” rating and a $12.00 target price for the company. Finally, Citigroup raised their target price on Infleqtion from $20.00 to $22.00 and gave the company a “buy” rating in a research report on Friday, August 21st.
Get Our Latest Research Report on Infleqtion
Infleqtion Price Performance
NYSE INFQ opened at $8.14 on Thursday. The business has a fifty day simple moving average of $11.88 and a 200 day simple moving average of $12.54. Infleqtion has a 12 month low of $8.05 and a 12 month high of $21.28.
Infleqtion (NYSE:INFQ – Get Free Report) last issued its quarterly earnings data on Wednesday, August 12th. The quantum tech company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.04). The business had revenue of $13.54 million during the quarter. On average, analysts anticipate that Infleqtion will post -0.24 earnings per share for the current year.
Insiders Place Their Bets
In related news, Director Maverick Capital Ltd sold 164,824 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $13.02, for a total value of $2,146,008.48. Following the completion of the transaction, the director directly owned 1,381,233 shares of the company’s stock, valued at approximately $17,983,653.66. This trade represents a 10.66% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last ninety days, insiders sold 222,132 shares of company stock valued at $2,843,186.
Hedge Funds Weigh In On Infleqtion
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. S&G Foundation bought a new position in shares of Infleqtion in the second quarter worth approximately $154,164,000. Davis Asset Management L.P. bought a new stake in Infleqtion during the second quarter valued at approximately $27,783,000. Bank of New York Mellon Corp lifted its position in Infleqtion by 1,350.7% during the second quarter. Bank of New York Mellon Corp now owns 1,076,802 shares of the quantum tech company’s stock valued at $14,343,000 after purchasing an additional 1,002,576 shares during the last quarter. Pinnacle Associates Ltd. grew its stake in Infleqtion by 42.4% in the 3rd quarter. Pinnacle Associates Ltd. now owns 1,045,860 shares of the quantum tech company’s stock worth $14,088,000 after buying an additional 311,280 shares in the last quarter. Finally, Integrated Advisors Network LLC grew its stake in Infleqtion by 58.2% in the 3rd quarter. Integrated Advisors Network LLC now owns 724,335 shares of the quantum tech company’s stock worth $9,757,000 after buying an additional 266,602 shares in the last quarter.
Infleqtion Company Profile
We are a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.
See Also
- Five stocks we like better than Infleqtion
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Infleqtion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Infleqtion and related companies with MarketBeat.com's FREE daily email newsletter.
